An update on psychogenic movement disorders

Current Neurology and Neuroscience Reports

Volumn 11, Issue 4, 2011, Pages 396-403

  Ellenstein, Aviva ^a   Kranick, Sarah M ^a   Hallett, Mark ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Diagnostic technique; Dissociative disorder; Functional disorder; Hysterical; Medically unexplained; Motor conversion; Movement disorder; Neurologic symptom; Psychogenic; Somatoform disorder

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; PAROXETINE; PLACEBO; VENLAFAXINE;

ACUPUNCTURE; ARTICLE; CONVERSION DISORDER; DISEASE ASSOCIATION; GENETIC ANALYSIS; HUMAN; HYPNOSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; NEUROSCIENCE; PHYSIOTHERAPY; PLACEBO EFFECT; PSYCHIATRIC DIAGNOSIS; PSYCHOGENIC MOVEMENT DISORDER; PSYCHOTHERAPY; BIOLOGICAL MODEL; MENTAL DISEASE; MOTOR DYSFUNCTION; NEUROLOGY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHIATRY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; REVIEW;

CONVERSION DISORDER; HUMANS; MENTAL DISORDERS; MODELS, NEUROLOGICAL; MOVEMENT DISORDERS; NERVOUS SYSTEM DISEASES; NEUROLOGY; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHIATRY;

EID: 80054816881     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-011-0205-z     Document Type: Article

References (50)

1. Hallett M, Fahn S, Jankovic J, et al. Psychogenic movement disorders: neurology and neuropsychiatry. Philadelphia: Lippincott Williams & Wilkins; 2006.
2. Bogousslavsky J. Hysteria after Charcot: back to the future. Front Neurol Neurosci. 2011;29:137-61.
3. Hallett M. Psychogenic movement disorders: a crisis for neurology. Curr Neurol Neurosci Rep. 2006;6:269-71. (Pubitemid 44069966)
4. Nowak DA, Fink GR. Psychogenic movement disorders: aetiology, phenomenology, neuroanatomical correlates and therapeutic approaches. Neuroimage. 2009;47:1015-25.
5. Stone J, Wojcik W, Durrance D, et al. What should we say to patients with symptoms unexplained by disease? The "number needed to offend". BMJ. 2002;325:1449-50. (Pubitemid 36026792)
6. Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol. 1988;50:431-55.
7. Williams DT, Ford B, Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol. 1995;65:231-57.
8. American Psychiatric Association, American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington: American Psychiatric Association; 2000.
9. Kranick SM, Ellenstein A, Hallett M. Psychiatric comorbidities and risk factors in psychogenic movement disorders: a biopsychosocial approach. European Neurological Journal. 2010;2:1-7.
10. Krem MM. Motor conversion disorders reviewed from a neuropsychiatric perspective. J Clin Psychiatry. 2004;65:783-90.
11. Scott RL, Anson JG. Neural correlates of motor conversion disorder. Mot Control. 2009;13:161-84.
12. Vuilleumier P. The Neurophysiology of Self-Awareness Disorders in Conversion Hysteria. In The Neurology of Consciousness Cognitive Neuroscience and Neuropathology. Edited by Laureys S and Tononi G. Academic Press; 2009:282-302. This chapter cogently discusses the neuroimaging and neurophysiologic studies of conversion hysteria in the context a developing neurobiological model that includes disrupted mechanisms of self-awareness.
13. Stone J, Carson A. Movement disorders: psychogenic movement disorders: what do neurologists do? Nat Rev Neurol. 2009;5:415-6.
14. LaFrance Jr WC, Miller IW, Ryan CE, et al. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2009;14:591-6.
15. Stone J, LaFrance WC, Jr., Levenson JL, et al. Issues for DSM-5: Conversion disorder. Am J Psychiatry, 167:626-627.
16. Mayou R, Kirmayer LJ, Simon G, et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry. 2005;162:847-55. (Pubitemid 40676195)
17. Lowe B, Mundt C, Herzog W, et al. Validity of current somatoform disorder diagnoses: perspectives for classification in DSM-V and ICD-11. Psychopathology. 2008;41:4-9. (Pubitemid 350146907)
18. Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology. 2010;74:223-8.
19. Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain. 2010;133:1526-36.
20. Hallett M. Physiology of psychogenic movement disorders. J Clin Neurosci. 2010;17:959-65.
21. Vuilleumier P, Chicherio C, Assal F, et al. Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain. 2001;124:1077-90. (Pubitemid 32510376)
22. de Lange FP, Roelofs K, Toni I. Increased self-monitoring during imagined movements in conversion paralysis. Neuropsychologia. 2007;45:2051-8. (Pubitemid 46654113)
23. Cojan Y, Waber L, Carruzzo A, et al. Motor inhibition in hysterical conversion paralysis. Neuroimage. 2009;47:1026-37.
24. de Lange FP, Toni I, Roelofs K. Altered connectivity between prefrontal and sensorimotor cortex in conversion paralysis. Neuropsychologia. 2010;48:1782-8.
25. Stone J, Vuilleumier P, Friedman JH. Conversion disorder: separating "how" from "why". Neurology. 2010;74:190-1.
26. Gaig C, Marti MJ, Tolosa E, et al. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism. Mov Disord. 2006;21:1994-8. (Pubitemid 44848954)
27. Hallett M: Psychogenic Parkinsonism. J Neurol Sci 2011. doi: 10.1016/j.jns.2011.03.019
28. Liepert J, Hassa T, Tuscher O, et al. Motor excitability during movement imagination and movement observation in psychogenic lower limb paresis. J Psychosom Res. 2010;70:59-65.
29. Desmurget M, Sirigu A. A parietal-premotor network for movement intention and motor awareness. Trends Cogn Sci. 2009;13:411-9.
30. Schwingenschuh P, Katschnig P, Edwards MJ, et al. The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm. Neurology. 2011;76:610-4.
31. Hariri AR. The neurobiology of individual differences in complex behavioral traits. Annu Rev Neurosci. 2009;32:225-47.
32. Caspi A, Hariri AR, Holmes A, et al. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. AmJ Psychiatry 2010, 167:509-527. Following from a detailed review of the serotonin transporter gene and stress sensitivity, the authors discuss approaches to the challenging field of gene-environment research.
33. Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci. 2006;7:583-90. (Pubitemid 43995433)
34. Hallett M, Lang AE, Jankovic J, et al. Psychogenic movement disorders & other conversion disorders. Cambridge: Cambridge University Press; 2011.
35. Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci. 2009;10:446-57.
36. Lupien SJ, McEwen BS, Gunnar MR, et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009,10:434-445. The authors synthesize the animal and human research on the age-dependent pathophysiology of stress.
37. Feinstein A, Stergiopoulos V, Fine J, et al. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:169-76. (Pubitemid 32751436)
38. Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry. 2005;66:1529-34. (Pubitemid 43068691)
39. Binder EB, Owens MJ, Liu W, et al. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Arch Gen Psychiatry. 2010;67:369-79.
40. Zhou Z, Zhu G, Hariri AR, et al. Genetic variation in human NPY expression affects stress response and emotion. Nature. 2008;452:997-1001. (Pubitemid 351589618)
41. Stone J. The bare essentials: Functional symptoms in neurology. Pract Neurol 2009, 9:179-189. This article presents important, practical advice for the neurologist's approach to patients with CD.
42. Hinson VK, Weinstein S, Bernard B, et al. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006;12:177-80.
43. Speckens AE, van Hemert AM, Spinhoven P, et al. Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial. BMJ. 1995;311:1328-32.
44. LaFrance Jr WC. Friedman JH. cognitive behavioral therapy for psychogenic movement disorder. Mov Disord. 2009;24:1856-7.
45. Baslet G, Hill J. Case report: brief mindfulness-based psychotherapeutic intervention during inpatient hospitalization in a patient with conversion and dissociation. Clinical Case Studies 2011. doi: 10.1177/1534650110396359.
46. Goldstein LH, Chalder T, Chigwedere C, et al. Cognitivebehavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology. 2010;74:1986-94.
47. Dallocchio C, Arbasino C, Klersy C, et al. The effects of physical activity on psychogenic movement disorders. Mov Disord. 2010;25:421-5.
48. Van Nuenen BF, Wohlgemuth M, Wong Chung RE, et al. Acupuncture for psychogenic movement disorders: treatment or diagnostic tool? Mov Disord. 2007;22:1353-5. (Pubitemid 47325051)
49. Moene FC, Spinhoven P, Hoogduin KA, et al. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn. 2003;51:29-50. (Pubitemid 36676057)
50. Chastan N, Parain D. Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord. 2010;25:1501-4.